
|Articles|October 30, 2006
AAIPharma Completes Acquisition of CAC and Launches New Business Unit
AAIPharma Completes CAC Acquisition
Advertisement
Wilmington, N.C., October 26, 2006--AAIPharma Inc. announced today that it has completed the previously announced acquisition of Cvitkovic & Associès Consultants S.A. (CAC), an international contract research organization specializing in oncology drug development and medical consulting. CAC has clinical operations in France, Croatia, Russia, Spain, Argentina, Peru, Australia, and the United States. As a result of the acquisition, CAC has become the foundation of AAIOncology, a global business unit dedicated to oncology drug development.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: What Real-Time Patient Data Is Doing to ClinOps Efficiency
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
5




